- DocumentoFR. EMMANUEL LEMELSONcaricato daamvona
- DocumentoFr. Emmanuel Lemelsoncaricato daamvona
- DocumentoFr. Emmanuel Lemelsoncaricato daamvona
- DocumentoRev. Fr. Emmanuel Lemelson files Writ of Certiorari with US Supreme Court in Unprecedented 9-year SEC Fightcaricato daamvona
- DocumentoOrdination Address - Holy Priesthoodcaricato daamvona
- DocumentoFr. Emmanuel Lemelson' court-ordered affidavit of religious affiliationcaricato daamvona
- DocumentoFr. Emmanuel Lemelson Files Opposition in SEC Fight over Ligand Pharmaceuticals (NASDAQcaricato daamvona
- DocumentoFr. Emmanuel Files Motion for Summary Judgment in SEC Fight over Ligand Pharmaceuticalscaricato daamvona
- DocumentoFederal Magistrate Judge Denies SEC Motion for Protective Order in Lemelson Fightcaricato daamvona
- DocumentoOpposition to The SEC's Motion for Protective Ordercaricato daamvona
- DocumentoLemelson Capital Management, LLC released the following note today to investors in The Amvona Fund, LP. regarding the extraordinary market volatility on May 7, 2019caricato daamvona
- DocumentoInvestors Sue Ligand Pharmaceuticals (NASDAQcaricato daamvona
- DocumentoREPLY MEMORANDUM IN SUPPORT OF DEFENDANTS’ MOTION TO DISMISScaricato daamvona
- DocumentoDEFENDANTS’ MEMORANDUM OF LAW IN SUPPORT OF THEIR MOTION TO DISMISScaricato daamvona
- DocumentoRev. Fr. Emmanuel Lemelson Calls on Congress, Office of Inspector General to Investigate SEC Failurescaricato daamvona
- DocumentoLemelson Capital Wants to Toss Geospace Execscaricato daamvona
- DocumentoA Valentine’s day letter to the Board of Directors of Geospace Technologiescaricato daamvona
- DocumentoLemelson Capital Management calls for Removal of Geospace Technologies (NASDAQcaricato daamvona
- DocumentoLemelsoncaricato daamvona
- DocumentoLetter to Gary Owen - BoD Geospace Technologies Corporation (NASDAQcaricato daamvona
- DocumentoPlaintiffs' Motioncaricato daamvona
- DocumentoMaster Investor Magazine - Fund Manager in Focuscaricato daamvona
- DocumentoFr. Emmanuel Lemelson Letter to Congress Regarding Ligandcaricato daamvona
- DocumentoThe Amvona Fund LP 4Y Partnership Lettercaricato daamvona
- Documento$100 Million Defamation Suit Filed against Bloomberg L.P., Reporter Matt Robinson and Editor Jesse Westbrookcaricato daamvona
- DocumentoLigand Pharmaceuticals - Severe Competitive Threat to Key Royalty Program and "going concern" risk drive 100 percent downsidecaricato daamvona
- DocumentoLigand Pharmaceuticals - Appendixcaricato daamvona
- DocumentoExcerpt From the Amvona Fund LP 2015 Annual Report on Geospace Technologiescaricato daamvona
- DocumentoHope This Helpscaricato daamvona
- DocumentoSt George Letter to WSJ editor 8 Nov 2015caricato daamvona
- DocumentoSt George Letter to WSJ editor 31 OCT 2015caricato daamvona
- DocumentoSt George Letter to WSJ editor 27 OCT 2015caricato daamvona
- DocumentoNewspaper Reporter - Thou Shalt Be Truthfulcaricato daamvona
- DocumentoOur Visiting Priest, Father Emmanuel Lemelson « Saint George Greek Orthodox Churchcaricato daamvona
- DocumentoLemelson Capital featured in HFMWeekcaricato daamvona
- DocumentoHigh-Flying Fund May Bar Entrycaricato daamvona
- DocumentoSNL Kagan - Interview with Lemelson Capital Management - Part 2caricato daamvona
- DocumentoSNL Kagan - Interview with Lemelson Capital Management - Part 1caricato daamvona